Komori
Art Vivant (7523) · RiskRevenue down, profit up after closing unprofitable locations

Profitability deterioration in the health industry business due to front-loaded store opening costs for "AMIDA"

First written in FY2017-Q2. 13 of 30 entries say "Mitigated", first in FY2019-Q1. Latest entry: FY2026.

30entries
11years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2017-Q2 – FY2018-Q3MitigatedFY2019-Q1 – FY2020WorsenedFY2023 – FY20242016: 12017: 320172018: 320182019: 420192020: 420202021: 420212022: 220222023: 120232024: 320242025: 220252026: 32026
Same theme, other companies
Deteriorating Health Industry Business earnings due to upfront costs for new Amiida storesA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026Revenue down, profit up after closing unprofitable locationsAnnual report

    「In the hot yoga business, the company focused on attracting new members and preventing cancellations, while closing unprofitable locations. As a result, revenue was ¥924 million, down 7.5% year on year, and operating profit was ¥92 million, up 4.8%.」

    Although the health business reported lower revenue due to the closure of unprofitable locations, operating profit increased.
  2. FY2026-H1Revenue and profit down after closing unprofitable locationsAnnual report

    「However, revenue was ¥459 million, down 9.1% year on year, and operating profit was ¥42 million, down 8.9%. The main reason for the decline in revenue was the closure of unprofitable locations.」

    The health business reported lower revenue and profit due to the closure of unprofitable locations, but secured operating profit of ¥42 million.
  3. FY2025MitigatedAnnual report

    「As a result, revenue was ¥999 million, down 21.9% year on year, due to the loss of revenue from "Karna Fitness & Spa Kashiwa," the fitness business location that closed in December 2023. However, operating profit was ¥88 million, compared with an operating loss of ¥64 million in the previous period.」

    Following the closure of the fitness business, the health business reported lower revenue but shifted from an operating loss to operating profit of ¥88 million, improving profitability.
  4. FY2025-H1MitigatedAnnual report

    「As a result, revenue was ¥505 million, down 26.8% year on year, and operating profit was ¥46 million, compared with an operating loss of ¥42 million in the same quarter of the previous year.」

    Although the health business reported lower revenue due to the closure of the fitness business, it shifted from an operating loss to operating profit of ¥46 million, improving profitability.
  5. FY2024WorsenedAnnual report

    「As a result, revenue was ¥1,279 million, down 10.6% year on year, and the operating loss was ¥64 million, compared with an operating loss of ¥19 million in the previous period.」

    The health business reported lower revenue, and the operating loss increased from ¥19 million in the previous period to ¥64 million. As membership retention remained difficult, Karna Kashiwa closed and the fitness business was discontinued.
  6. FY2024-Q3WorsenedAnnual report

    「As a result, revenue was ¥1,019 million, down 5.2% year on year, and the operating loss was ¥70 million, compared with an operating loss of ¥13 million in the same quarter of the previous year.」

    Membership retention remained difficult in the health business, with revenue down 5.2% year on year and the operating loss increasing from ¥13 million in the same period of the previous year to ¥70 million.
  7. FY2023WorsenedAnnual report

    「As a result, revenue was ¥1,430 million, down 7.0% year on year, and the operating loss was ¥19 million, compared with operating profit of ¥8 million in the previous period.」

    The health business reported lower revenue and shifted from operating profit in the previous period to an operating loss.
  8. FY2022MitigatedAnnual report

    「As a result, revenue was ¥1,538 million, up 10.6% year on year, and operating profit was ¥8 million, compared with an operating loss of ¥50 million in the previous period.」

    Although membership numbers remained under severe pressure, the health business improved from an operating loss to operating profit of ¥8 million.
  9. FY2022-Q3RestatedAnnual report

    「As a result, revenue was ¥1,168 million, up 18.4% year on year, and operating profit was ¥3 million, compared with an operating loss of ¥58 million in the same quarter of the previous year.」

    Although membership numbers remained under severe pressure in the health business, the business maintained its shift from an operating loss to operating profit through the cumulative third quarter.
  10. FY2022-Q2MitigatedAnnual report

    「In the hot yoga and fitness businesses, many members froze or cancelled their memberships after the closure of stores due to the state of emergency declared in April and May 2020. Membership numbers have gradually recovered since then, but remain under severe pressure. As a result, revenue was ¥785 million, up 43.4% year on year, and operating profit was ¥5 million, compared with an operating loss of ¥92 million in the same quarter of the previous year.」

    Although membership numbers remained under severe pressure, the health business improved from an operating loss of ¥92 million in the same period of the previous year to operating profit of ¥5 million.
  11. FY2022-Q1MitigatedAnnual report

    「As a result, revenue was ¥393 million, up 159.8% year on year, and the operating loss was ¥3 million, compared with an operating loss of ¥64 million in the same quarter of the previous year.」

    The health business reduced its loss from an operating loss of ¥64 million in the same period of the previous year to ¥3 million in the current quarter, while revenue increased 159.8% year on year. Meanwhile, membership numbers remained under pressure.
  12. FY2021WorsenedAnnual report

    「Membership numbers subsequently remained weak, declining approximately 31% from the number at the end of the previous period. As a result, revenue in the health business was ¥1,391 million, down 32.4% from the previous period, and the operating loss was ¥50 million, compared with operating profit of ¥81 million in the previous period.」

    The health business reported lower revenue due to a decline in membership numbers and shifted from operating profit in the previous period to an operating loss.
  13. FY2021-Q3WorsenedAnnual report

    「As membership numbers remained difficult, revenue was ¥986 million, down 35.4% year on year, and the operating loss was ¥58 million, compared with operating profit of ¥34 million in the same quarter of the previous year. In addition, ¥150 million in COVID-19-related costs was recognized as an extraordinary loss.」

    Membership numbers remained under pressure in the health business, with revenue down 35.4% year on year and the business shifting from operating profit in the same period of the previous year to an operating loss. COVID-19-related costs of ¥150 million were also recognized.
  14. FY2021-Q2WorsenedAnnual report

    「As a result, revenue was ¥547 million, down 45.4% year on year, and the operating loss was ¥92 million, compared with operating profit of ¥26 million in the same quarter of the previous year. In addition, ¥150 million in COVID-19-related costs was recognized as an extraordinary loss.」

    Revenue in the health business fell 45.4% year on year, and the business deteriorated from operating profit of ¥26 million in the same period of the previous year to an operating loss of ¥92 million. COVID-19-related costs of ¥150 million were also recognized as an extraordinary loss.
  15. FY2021-Q1WorsenedAnnual report

    「As a result, revenue was ¥151 million, down 69.5% year on year, and the operating loss was ¥64 million, compared with operating profit of ¥7 million in the same quarter of the previous year.」

    In the health business, revenue fell 69.5% year on year due to the impact of store closures and other factors related to COVID-19, and the business shifted from operating profit in the same period of the previous year to an operating loss.
  16. FY2020MitigatedAnnual report

    「As a result, revenue was ¥2,059 million, up 24.2% year on year, and operating profit was ¥81 million, up 584.5%.」

    Operating profit in the health business was ¥81 million, up from ¥11 million in the same period of the previous year. Improvement from the deterioration caused by up-front opening costs for Amiida locations was also confirmed for the full year.
  17. FY2020-Q3MitigatedAnnual report

    「As a result, revenue was ¥1,527 million, up 28.2% year on year, and operating profit was ¥34 million, up 175.7%.」

    The health business generated revenue of ¥1,527 million, up 28.2% year on year, and operating profit of ¥34 million, up 175.7%, with continued improvement from the deterioration caused by opening costs being incurred ahead of revenue generation.
  18. FY2020-Q2MitigatedAnnual report

    「As a result, revenue was ¥1,002 million, up 32.9% year on year, and operating profit was ¥26 million, up 175.7%.」

    Operating profit in the health business was ¥26 million, up 175.7% year on year, representing continued improvement. Meanwhile, an impairment loss of ¥23.298 million was recognized for assets designated for withdrawal from Amiida.
  19. FY2020-Q1MitigatedAnnual report

    「As a result, revenue was ¥495 million, up 40.2% year on year, and operating profit was ¥7 million, up 169.2%.」

    Operating profit in the health business was ¥7 million, up 169.2% year on year. However, an impairment loss of ¥22.324 million was recognized for assets designated for withdrawal from Amiida.
  20. FY2019MitigatedAnnual report

    「As a result, revenue was ¥1,657 million, up 76.8% year on year, and despite the opening costs for "Amiida" locations being incurred ahead of revenue generation, operating profit was ¥11 million, compared with an operating loss of ¥110 million in the same period of the previous year.」

    Although up-front opening costs for Amiida locations continued, the health business improved from an operating loss of ¥110 million in the same period of the previous year to operating profit of ¥11 million.
  21. FY2019-Q3MitigatedAnnual report

    「As a result, revenue was ¥1,190 million, up 85.5% year on year, and despite the opening costs for "Amiida" locations being incurred ahead of revenue generation, operating profit was ¥12 million, compared with an operating loss of ¥104 million in the same quarter of the previous year.」

    Although up-front opening costs for Amiida locations continued, the health business improved from an operating loss of ¥104 million in the same period of the previous year to operating profit of ¥12 million.
  22. FY2019-Q2MitigatedAnnual report

    「As a result, revenue was ¥754 million, up 94.7% year on year, and despite the opening costs for "Amiida" locations being incurred ahead of revenue generation, operating profit was ¥9 million, compared with an operating loss of ¥70 million in the same quarter of the previous year.」

    Although up-front opening costs for Amiida locations continued, the health business improved from an operating loss of ¥70 million in the same period of the previous year to operating profit of ¥9 million. In addition, an impairment loss of ¥32.670 million was recognized for assets designated for withdrawal.
  23. FY2019-Q1MitigatedAnnual report

    「As a result, revenue was ¥353 million, up 107.7% year on year, and despite the opening costs for "Amiida" locations being incurred ahead of revenue generation, operating profit was ¥2 million, compared with an operating loss of ¥41 million in the same quarter of the previous year.」

    Although up-front opening costs for Amiida locations continued, the health business improved from an operating loss of ¥41 million in the same period of the previous year to operating profit of ¥2 million.
  24. FY2018-Q3WorsenedAnnual report

    「As a result, revenue was ¥642 million, up 72.6% year on year, but because the opening costs for "Amiida" locations were incurred ahead of revenue generation, the operating loss was ¥104 million, compared with operating profit of ¥15 million in the same quarter of the previous year.」

    Up-front opening costs for Amiida locations continued, and the health business deteriorated from operating profit of ¥15 million in the same period of the previous year to an operating loss of ¥104 million. In addition, an impairment loss of ¥99.908 million was recognized for the asset group designated for withdrawal.
  25. FY2018-Q2WorsenedAnnual report

    「In addition, the company began rolling out "Amiida," a women-only hot yoga studio using lava stone, in July 2016 and has been opening locations sequentially, with 12 locations as of the end of September 2017, including pre-opening sites. As a result, revenue was ¥387 million, up 61.3% year on year, but because the opening costs for "Amiida" locations were incurred ahead of revenue generation, the operating loss was ¥70 million, compared with operating profit of ¥15 million in the same quarter of the previous year.」

    Costs incurred ahead of revenue generation continued as Amiida locations were opened sequentially, and the health business deteriorated from operating profit of ¥15 million in the same period of the previous year to an operating loss of ¥70 million.
  26. FY2018-Q1WorsenedAnnual report

    「In addition, the company began rolling out "Amiida," a women-only hot yoga studio using lava stone, in July 2016 and has been opening locations sequentially. As a result, revenue was ¥170 million, up 42.6% year on year, but because the opening costs for "Amiida" locations were incurred ahead of revenue generation, the operating loss was ¥41 million, compared with operating profit of ¥10 million in the same quarter of the previous year.」

    Up-front opening costs for "Amiida" locations continued, and the health business deteriorated from operating profit of ¥10 million in the same period of the previous year to an operating loss of ¥41 million.
  27. FY2017-Q3WorsenedAnnual report

    「As a result, revenue was ¥371 million, up 3.0% year on year, but as the opening costs for "Amiida" locations were incurred ahead of revenue generation, operating profit was ¥15 million, down 69.0%.」

    Up-front opening costs for Amiida locations continued, and operating profit in the health business was ¥15 million, down 69.0% year on year.
  28. FY2017-Q2MaterialisedAnnual report

    「However, due to a slight decline in the number of members at "Karna Kashiwa," revenue was ¥240 million, down 0.6% from the same quarter of the previous year. As the opening costs for "Amiida" locations were incurred ahead of revenue generation, operating profit was ¥15 million, down 55.2%.」

    A slight decline in members at Karna Kashiwa and up-front opening costs for Amiida locations caused operating profit in the health business to fall 55.2% year on year.
Moved together

"Extraordinary loss associated with the relocation of the head office and closure of a store" moved the same way as this thread, in the same document, in 15 of its 30 moves.

15111111108★123456
  1. ★This thread
  2. 1Extraordinary loss associated with the relocation of the head office and closure of a store15×
  3. 2Expansion of the women-only hot yoga studio “AMI-DA”11×
  4. 3Collection risk on long-term loans to major shareholders11×
  5. 4Companywide revenue and profit growth; recovery in ordinary profit11×
  6. 5Losses on Store Closures Associated with the Scrap-and-Build of Unprofitable Stores10×
  7. 6Enhancing shareholder value and paying dividends at the highest level possible8×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Art Vivant yet. It last moved in the General Meetings of Shareholders of 2026-06-02: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Profitability deterioration in the health industry business due to front-loaded store opening costs for "AMIDA" | ART VIVANT CO.,LTD. (7523) | Komori